MedTrace Logo

Distal Venous Arterialisation of Ischemic Limb

NCT01211925 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2010-09-30

No results posted yet for this study

Summary

Distal venous arterialisation (DVA) improve outcome in patients with nonreconstructible peripheral arterial occlusive disease.

Conditions

  • Critical Limb Ischemia

Interventions

PROCEDURE

distal venous arterialisation

The investigators perform reverse revascularisation of the ischemic limb with arterial blood supply from patent in flow artery to the superficial dorsal venous arch.

DRUG

Aspirin

100 mg per day continuous

Sponsors & Collaborators

Principal Investigators

  • Predrag Vl Djoric, MD · Clinical Center of Serbia in Belgrade, Clinic for Vascular and Endovascular Surgery

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2010-07-31
Completion
2011-07-31

Countries

  • Serbia

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01211925 on ClinicalTrials.gov